- Author:
Ji Yeon JUNG
1
;
Sang Jin OH
Author Information
- Publication Type:Original Article
- Keywords: Tumor suppressor gene; p53 mutation; colon cancer cell line; PCR-SSCP; SNU C2A cell
- MeSH: Alleles; Animals; Arginine; Blotting, Northern; Blotting, Western; Carcinogenesis; Cats; Cell Line*; Cell Proliferation; Codon; Colon*; Colonic Neoplasms*; Exons; Genes, p53; Genes, Tumor Suppressor; Histidine; Humans; Immunoprecipitation; Incidence; Mutation, Missense; Point Mutation; RNA, Messenger; Sequence Analysis, DNA; Transcriptional Activation
- From:Immune Network 2001;1(2):151-161
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Inactivation in p53 tumor suppressor gene through a point mutation and deletion is one of the most frequent genetic changes found in human cancer, with 50% of an incidence. This high rate of mutation mostly suggests that the gene plays a central role in the development of cancer and the mutations detected so far were found in exons 5 to 8. Mutation of p53 locus produced accumulation of abnormal p53 protein, and negative regulation of cell proliferation and transcriptional activation as a suppressor of transformation were lost . In addition, inhibition of its normal cellular function of wild-type by mutant is an important step in tumorigenesis. METHOD: 4 colon cancer cell lines (SNU C1, C2A, C4, C5) were examined for mutation in exons 5 to 8 of the p53 tumor suppressor gene by PCR-SSCP analysis and expression pattern by western blotting and immunoprecipitation. p53-mediated transactivation ability were examined by CAT assay and base substitution of p53 in SNU C2A cell were detected by DNA sequencing. RESULTS: 1) SNU C2A cell and SNU C5 cell were detected mobility shifts each in exon 5 and exon 7 of p53 gene by the PCR-SSCP method, implicating being of p53 mutation. 2) 3 colon cancer cell lines (SNU C1, SNU C2A, SNU C5) expressed wild type and mutant type p53 protein. 3) In northern blot experiment, SNU C2A and SNU C5 cell expressed high level of p53 mRNA. 4) Results of p53-mediated transactivation in colon cancer cell lines by CAT assay represented only SNU C2A cell has transcriptional activity. 5) DNA sequencing in SNU C2A cell showed missense mutation in codon 179 of one allele, histidine to arginine and wild type p53 in the other allele. CONCLUSION: Colon cancer cell lines showed correlation with mutation in p53 gene and accumulation of abnormal p53 protein. Colon cancer cell SNU C2A retained p53-mediated transactivation as heterozygous p53 with one mutant allele in 179 codon and the other wild-type allele.